Another interesting heterozygous deletion encompassing GGTLC2 was found significantly higher in controls as compared to ALS patients, suggesting a potential protective role of this variant against the risk of developing ALS (Table 1). Here, GGTLC2 is linked to amyotrophic lateral sclerosis.